84 related articles for article (PubMed ID: 28901504)
21. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
[TBL] [Abstract][Full Text] [Related]
22. Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis.
Lee MS; Ghim J; Kim SJ; Yun YS; Yoo SA; Suh PG; Kim WU; Ryu SH
Cell Signal; 2015 Jul; 27(7):1439-48. PubMed ID: 25862954
[TBL] [Abstract][Full Text] [Related]
23. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
Takahashi Y; Cleary KR; Mai M; Kitadai Y; Bucana CD; Ellis LM
Clin Cancer Res; 1996 Oct; 2(10):1679-84. PubMed ID: 9816116
[TBL] [Abstract][Full Text] [Related]
24. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
26. Both hydrogen peroxide and transforming growth factor beta 1 contribute to endothelial Nox4 mediated angiogenesis in endothelial Nox4 transgenic mouse lines.
Chen L; Xiao J; Kuroda J; Ago T; Sadoshima J; Cohen RA; Tong X
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2489-99. PubMed ID: 25315297
[TBL] [Abstract][Full Text] [Related]
27. The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer.
Liu SG; Yuan SH; Wu HY; Liu J; Huang CS
Cell Biochem Biophys; 2015 May; 72(1):165-9. PubMed ID: 25548002
[TBL] [Abstract][Full Text] [Related]
28. SP1/TGF‑β1/SMAD2 pathway is involved in angiogenesis during osteogenesis.
Ding A; Bian YY; Zhang ZH
Mol Med Rep; 2020 Mar; 21(3):1581-1589. PubMed ID: 32016481
[TBL] [Abstract][Full Text] [Related]
29. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
Mallet C; Vittet D; Feige JJ; Bailly S
Stem Cells; 2006 Nov; 24(11):2420-7. PubMed ID: 17071858
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
[TBL] [Abstract][Full Text] [Related]
31. The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction.
Kim BM; Lee DH; Choi HJ; Lee KH; Kang SJ; Joe YA; Hong YK; Hong SH
IUBMB Life; 2012 Mar; 64(3):259-65. PubMed ID: 22252975
[TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
33. Investigating the role of angiogenesis in systemic lupus erythematosus.
Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
[TBL] [Abstract][Full Text] [Related]
34. High expression of transform growth factor beta 1 in gastric cancer confers worse outcome: results of a cohort study on 184 patients.
Hu WQ; Wang LW; Yuan JP; Yan SG; Li JD; Zhao HL; Peng CW; Yang GF; Li Y
Hepatogastroenterology; 2014; 61(129):245-50. PubMed ID: 24895830
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-210 Plays a Critical Role in the Angiogenic Effect of Isoprenaline on Human Umbilical Vein Endothelial Cells via Regulation of Noncoding RNAs.
Yan YY; Wang ZH; Zhao L; Song DD; Qi C; Liu LL; Wang JN
Chin Med J (Engl); 2016 Nov; 129(22):2676-2682. PubMed ID: 27823999
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
38. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer.
Ding S; Lin S; Dong X; Yang X; Qu H; Huang S; Liu W; Zhou L; Liu D
In Vivo; 2005; 19(4):793-5. PubMed ID: 15999551
[TBL] [Abstract][Full Text] [Related]
39. Clinical correlations and prognostic relevance of tissue angiogenic factors in patients with gastric cancer.
Mohri Y; Miki C; Tanaka K; Kawamoto A; Ohi M; Yokoe T; Kusunoki M
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):610-6. PubMed ID: 22130629
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
